Skip navigation
  • Sciety Labs 🧪 (Experimental)
  • Search
Sciety application utilities

Bioengineering

  • Subscribe to feed (RSS)

Showing page 12 of 25 pages of list content

  • Engineering Defensin α-helix to produce high-affinity SARS-CoV-2 Spike protein binding ligands

    This article's authors
    1. Leonardo Antônio Fernandes
    2. Anderson Albino Gomes
    3. Maria de Lourdes Borba Magalhães
    4. Partha Ray
    5. Gustavo Felippe da Silva
    This article has 1 evaluations Latest evaluation on Feb 15, 2022 Published on Feb 10, 2022
  • Preclinical establishment of a divalent vaccine against SARS-CoV-2

    This article's authors
    1. Zsofia Hevesi
    2. Daniela Gerges
    3. Sebastian Kapps
    4. Raimundo Freire
    5. Sophie Schmidt
    6. Daniela D. Pollak
    7. Klaus Schmetterer
    8. Tobias Frey
    9. Rita Lang
    10. Wolfgang Winnicki
    11. Alice Schmidt
    12. Tibor Harkany
    13. Ludwig Wagner
    This article has 1 evaluations Latest evaluation on Feb 14, 2022 Published on Feb 15, 2022
  • Human Cardiac Organoids to Model COVID-19 Cytokine Storm Induced Cardiac Injuries

    This article's authors
    1. Dimitrios C Arhontoulis
    2. Charles Kerr
    3. Dylan Richards
    4. Kelsey Tjen
    5. Nathaniel Hyams
    6. Jefferey A. Jones
    7. Kristine Deleon-Pennell
    8. Donald Menick
    9. Diana Lindner
    10. Dirk Westermann
    11. Ying Mei
    This article has 1 evaluations Latest evaluation on Feb 4, 2022 Published on Feb 1, 2022
  • Genetically engineered insects with sex-selection and genetic incompatibility enable population suppression

    This article's authors
    1. Ambuj Upadhyay
    2. Nathan R Feltman
    3. Adam Sychla
    4. Siba R Das
    5. Maciej Maselko
    6. Michael J Smanski
    This article has 4 evaluations Latest evaluation on Feb 4, 2022 Published on Jun 11, 2021
  • Nanoformulated Remdesivir with Extremely Low Content of Poly(2-oxazoline) - Based Stabilizer for Aerosol Treatment of COVID-19

    This article's authors
    1. Jacob D. Ramsey
    2. Ian E. Stewart
    3. Emily A. Madden
    4. Chaemin Lim
    5. Duhyeong Hwang
    6. Mark T. Heise
    7. Anthony J. Hickey
    8. Alexander V. Kabanov
    This article has 1 evaluations Latest evaluation on Jan 25, 2022 Published on Jan 21, 2022
  • Targeting SARS-CoV-2 infection through CAR-T like bispecific T cell engagers incorporating ACE2

    This article's authors
    1. Mikail Dogan
    2. Lina Kozhaya
    3. Lindsey Placek
    4. Fatih Karabacak
    5. Mesut Yigit
    6. Derya Unutmaz
    This article has 1 evaluations Latest evaluation on Jan 24, 2022 Published on Apr 20, 2022
  • Immunokinetic Model for COVID-19 Patients

    This article's authors
    1. Y. Fadaei
    2. F. A. Rihan
    3. C Rajivganthi
    This article has 1 evaluations Latest evaluation on Jan 20, 2022 Published on Jan 18, 2022
  • Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape

    This article's authors
    1. Fangzhu Zhao
    2. Celina Keating
    3. Gabriel Ozorowski
    4. Namir Shaabani
    5. Irene M. Francino-Urdaniz
    6. Shawn Barman
    7. Oliver Limbo
    8. Alison Burns
    9. Panpan Zhou
    10. Michael J. Ricciardi
    11. Jordan Woehl
    12. Quoc Tran
    13. Hannah L. Turner
    14. Linghang Peng
    15. Deli Huang
    16. David Nemazee
    17. Raiees Andrabi
    18. Devin Sok
    19. John R. Teijaro
    20. Timothy A. Whitehead
    21. Andrew B. Ward
    22. Dennis R. Burton
    23. Joseph G. Jardine
    This article has 1 evaluations Latest evaluation on Jan 11, 2022 Published on Jan 7, 2022
  • Accelerating manufacturing to enable large-scale supply of a new adenovirus-vectored vaccine within 100 days

    This article's authors
    1. Carina C D Joe
    2. Rameswara R Segireddy
    3. Cathy Oliveira
    4. Adam Berg
    5. Yuanyuan Li
    6. Dimitrios Doultsinos
    7. Nitin Chopra
    8. Steffi Scholze
    9. Asma Ahmad
    10. Piergiuseppe Nestola
    11. Julia Niemann
    12. Alexander D Douglas
    This article has 1 evaluations Latest evaluation on Dec 28, 2021 Published on Dec 23, 2021
  • Arsenal of Nanobodies for Broad-Spectrum Countermeasures against Current and Future SARS-CoV-2 Variants of Concerns

    This article's authors
    1. M. A. Rossotti
    2. H. van Faassen
    3. A. Tran
    4. J. Sheff
    5. J. K. Sandhu
    6. D. Duque
    7. M. Hewitt
    8. S. Wen
    9. R. Bavananthasivam
    10. S. Beitari
    11. K. Matte
    12. G. Laroche
    13. P. M. Giguère
    14. C. Gervais
    15. M. Stuible
    16. J. Guimond
    17. S. Perret
    18. G. Hussack
    19. M.-A. Langlois
    20. Y. Durocher
    21. J. Tanha
    This article has 1 evaluations Latest evaluation on Dec 23, 2021 Published on Dec 21, 2021
Previous Next
Stay updated. Get involved.
Subscribe to Mailing List
  • Blog
  • About Sciety
  • Contact
  • Follow us on Twitter
  • Follow us on Facebook
© 2022 eLife Sciences Publications Ltd. Legal information